Brentuximab Vedotin (BV) in Combination With Lenalidomide (Len) and Rituximab (R) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Results From the Phase 3 ECHELON-3 Study

被引：0

作者：

Yasenchak, Christopher ^{[1
]}

Kim, Jeong-A ^{[2
]}

Hahn, Uwe ^{[3
]}

Kim, Won-Seog ^{[4
]}

Fleury, Isabelle ^{[5
]}

Laribi, Kamel ^{[6
]}

Bergua Burgues, Juan Miguel ^{[7
]}

Bouabdallah, Krimo ^{[8
]}

Forward, Nicholas ^{[9
]}

Bijou, Fontanet ^{[10
]}

MacDonald, David ^{[11
]}

Portell, Craig ^{[12
]}

Ghesquieres, Herve ^{[13
]}

Nowakowski, Grzegorz ^{[14
]}

Rustia, Evelyn ^{[15
]}

Fanale, Michelle ^{[15
]}

Jie, Fei ^{[15
]}

Bartlett, Nancy ^{[16
]}

机构：

[1] US Oncol Res, Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA

[2] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea

[3] Royal Adelaide Hosp, Haematol Unit, Adelaide, Australia

[4] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[5] Univ Montreal, Inst Univ Hematol Oncol & Therapie Cellulaire, Hop Maisonneuve Rosemon, Montreal, PQ, Canada

[6] Ctr Hosp Le Mans, Dept Hematol, Le Mans, France

[7] Hosp San Pedro Alcantara, Caceres, Spain

[8] CHU Haut Leveque, Serv Hematol Clin & Therapie Cellulaire, Pessac, France

[9] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[10] Ctr Lutte Canc CLCC Inst Bergonie, Bordeaux, France

[11] Ottawa Hosp, Div Hematol, Ottawa, ON, Canada

[12] Univ Virginia, UVA Comprehens Canc Ctr, Charlottesville, VA USA

[13] Hop Lyon Sud HCL, Pierre Benite, France

[14] Mayo Clin, Div Hematol, Rochester, NY USA

[15] Pfizer Inc, Bothell, WA USA

[16] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

ABCL; Diffuse large B-cell lymphoma; relapsed/refractory; phase; 3;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ABCL-711

引用

页码：S490 / S491

页数：2